- Home
- DOMH vs IMA Comparison
DOMH vs IMA Comparison
Compare DOMH & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- IMA
- Stock Information
- Founded
- DOMH 1967
- IMA 2019
- Country
- DOMH United States
- IMA United States
- Employees
- DOMH N/A
- IMA N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOMH Health Care
- IMA Health Care
- Exchange
- DOMH Nasdaq
- IMA Nasdaq
- Market Cap
- DOMH 94.0M
- IMA 92.2M
- IPO Year
- DOMH N/A
- IMA N/A
- Fundamental
- Price
- DOMH $6.47
- IMA $8.27
- Analyst Decision
- DOMH
- IMA
- Analyst Count
- DOMH 0
- IMA 0
- Target Price
- DOMH N/A
- IMA N/A
- AVG Volume (30 Days)
- DOMH 366.7K
- IMA 87.8K
- Earning Date
- DOMH 11-07-2025
- IMA 11-15-2025
- Dividend Yield
- DOMH 8.35%
- IMA N/A
- EPS Growth
- DOMH N/A
- IMA N/A
- EPS
- DOMH N/A
- IMA N/A
- Revenue
- DOMH $52,811,000.00
- IMA $4,300,000.00
- Revenue This Year
- DOMH N/A
- IMA N/A
- Revenue Next Year
- DOMH N/A
- IMA N/A
- P/E Ratio
- DOMH N/A
- IMA N/A
- Revenue Growth
- DOMH 455.38
- IMA N/A
- 52 Week Low
- DOMH $0.83
- IMA $7.57
- 52 Week High
- DOMH $13.58
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- DOMH 49.43
- IMA N/A
- Support Level
- DOMH $6.53
- IMA N/A
- Resistance Level
- DOMH $7.54
- IMA N/A
- Average True Range (ATR)
- DOMH 0.61
- IMA 0.00
- MACD
- DOMH -0.05
- IMA 0.00
- Stochastic Oscillator
- DOMH 14.75
- IMA 0.00
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.